Fill Out Your Profile to share more about you. Learn more...

Ibrance-Faslodex Combo Improves Overall Survival in Advanced HR+

Ibrance-Faslodex Combo Continues To Improve Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer
June 10, 2021

The latest results from the PALOMA-3 trial show that combining Ibrance and Faslodex continues to offer better overall survival than Faslodex alone. Read more...